Cell MedX Corp. announced the appointment by the board of directors of Dr. George Adams as Chairman of the Board. Dr. Adams has served on the board of directors of the Company since March 23, 2018 and was most recently CEO of Ventripoint Diagnostics, a medical devices company involved in the development of heart diagnostic devices for patients with heart disease. Previous to Ventripoint, his positions included CEO of Amorfix Life Sciences, Chairman of Sernova Corp. and President and CEO of the UT Innovations Foundation. He has held research and executive positions with Boston Scientific, Pfizer, Corvita Canada Inc. and the University of Ottawa and has been instrumental in founding over 30 companies and raising more than $100 million of equity financing. Dr. Adams has contributed more than 120 articles to scientific journals and was recognized as a Technology Pioneer by the World Economic Forum in 2007. As part of an ongoing corporate reorganization, Dr. Adams will be integral in guiding the Company's board
through the reorganization including the process of product redesign and enhancement and clinical trial implementations to further prove out eBalance functionality.